OK-432 treatment increases matrix metalloproteinase-9 production and improves dimethylnitrosamine-induced liver cirrhosis in rats

International Journal of Molecular Medicine

Volumn 3, Issue 5, 1999, Pages 497-503

  Ueno, Takato ^c   Sujaku, Kodo ^b   Tamaki, Seishu ^a   Rikoogata, ^a   Kin, Motoaki ^c   Toorunakamura, ^d   Sakamoto, Masaharu ^a   Takujitorimura, ^a   Mitsuyama, Keiichi ^b   Sakisaka, Shotaro ^a   Sata, Michio ^d   Tanikawa, Kyuichi ^a  

^a Second Department of Medicine

^b Kuruine University School of Medicine   (Japan)

^c International Institute for Liver Research   (Japan)

^d KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Dimethylnitrosaminc; Kupffer cell; Liver cirrhosis; Matrix mctalloprotcinasc; OK 432

Indexed keywords

ACTIN; BIOLOGICAL RESPONSE MODIFIER; COLLAGEN; COLLAGENASE; DIMETHYLNITROSAMINE; GELATINASE B; HYALURONIC ACID; MESSENGER RNA; PICIBANIL;

ANIMAL; ARTICLE; BIOSYNTHESIS; CHEMICALLY INDUCED DISORDER; EXPERIMENTAL LIVER CIRRHOSIS; GENETICS; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; RAT; WISTAR RAT;

ACTINS; ANIMALS; BIOLOGICAL RESPONSE MODIFIERS; COLLAGEN; COLLAGENASES; DIMETHYLNITROSAMINE; HYALURONIC ACID; IMMUNOHISTOCHEMISTRY; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; MATRIX METALLOPROTEINASE 9; PICIBANIL; RATS; RATS, WISTAR; RNA, MESSENGER;

EID: 0033128941     PISSN: 11073756     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijmm.3.5.497     Document Type: Article

References (24)

1. Okazaki I and Maruyama K: Collagenase activity in experimental hepatic fibrosis. Nature 252: 49-50, 1974.
2. Milani S, Herbst H, Schuppan D, Grappone C, Pellegrini G, Pinzani M, Casini A, Calabró A, Ciancio G, Stefanini F, Burroughs AK and Surrenti C: Differential expression of matrix metalloproteinase-l and -2 genes in normal and fibrotic human liver. Am J Pathol 144: 528-537, 1994.
3. Vyas SK, Lcyland H, Gentry J and Arthur MIP: Rat hepatic lipocytes synthesize and secrete transin (Stromelysin) in early primary culture. Gastroenterology 109: 888-898, 1995.
4. Takahara T, Furui K, Funaki J, et al: Increased expression of matrix metalloproteinase-II in experimental liver fibrosis in rats. Hepatology 21: 787-795,1995.
5. Casini A, Ceni E, Salzano R, Milani S, Schuppan D and Surrenti C: Acctaldchyde regulates the gene expression of matrix-metalloproteinase-l, and -2 in human fat-storing cells. Life Sei 55: 1311-1316,1994.
6. Winwood PJ, Schuppan D, Ircdale JP, Kawser CA, Docherty AJP and Arthur MJP: Kupffer cell-derived 95-kd type IV collagenase/ gelatinase B: characterization and expression in cultured cells. Hepatology 22: 304-315, 1995.
7. Petermann H, Heymann S, Vogel S and Dargel R: Phagocytic function and metabolize production in thioacetamide-induced liver cirrhosis: a comparative study in perfused livers and cultured Kupffer cells. J Hepatol 24:468-477, 1996.
8. Kamimura S and Tsukamoto H: Cytokine gene expression by Kupffer cells in experimental alcoholic liver disease. Hepatolosy 21:1304-1309,1995.
9. Tomita M, Yamamoto K, Kobayashi H, Ohmoto M and Tsuji T: Immunohistochemical phenotyping of liver macrophages in normal and diseased human liver. Hepatology 20: 317-325, 1994.
10. Kawada N, Mizoguchi Y, Kobayashi K, Monna T, Liu P and Morisawa S: Enhancement of prostaglandin E2 production by liver macrophages (Kupffer cells) after stimulation with biological response modifiers. Prostaclandins Leukotrienes Essent Fatty Acids 46: 105-110,1992.
11. VogI S, Junker U, Vogelsang H and Dargel R: Macrophages from rat livers with micronodular and macronodular cirrhosis differ with respect to mediator release and DNA-synthesis. J Hepatol 26: 1093-1103,1997.
12. Bouwcns L and Wisse E: Tissue localization and kinetics of pit cells or large granular lymphocytes in the liver of rats treated with biological response modifiers. Hepatology 8: 46-52, 1988.
13. Sujaku K, Ucno T, Torimura T, Sata M and Tanikawa K: Effects of OK-432 on matrix mctalloprotcinase-9 expression and activity in rat cultured Kupffer cells. Hepatol Res 10: 91-100, 1998.
14. Madden JW, Gertman PM and Peacock EE: Dimethylnitrosamineinduccd hepatic cirrhosis: a new canine model of an ancient human disease. Surgery 68: 260-268, 1970.
15. Aln-Kokko L, Pihlajaniemi T, Myers JC, Kivirikko KI and Savolaincn ER: Gene expression of type I, III, and IV collagens in hepatic fibrosis induced by dimethylnitrosamine in the rat. Biochem J 244: 75-79, 1987.
16. George J and Chandrakasan G: Molecular characteristics of dimethylnitrosamine induced fibrotic liver collagen. Biochem Biophys Acta 292: 1215-222,1996.
17. Chichibu K, Matsuura T, Shichijo S and Yokoyama M: Assay of serum hyaluronic acid in clinical application. Clin Chim Acta 181:317-324, 1989.
18. Ucno T, Tamaki S, Sugawara H, Inuzuka S, Torimura T, Sata M and Tamaki K: Significance of serum tissue inhibitor of metalloproteinases-1 in various liver diseases. J Hepatol 24: 177-184, 1996.
19. Xie B, Dong Z and Fidler IJ: Regulatory mechanisms for the expression of type IV collagenases/gelatinases in murine macrophages. J Immunol 12: 3637-3644, 1994.
20. Lacraz S, Nicod LP, Chicheportiche R, Welgus WG and Daycr JM: IL-10-inhibits mctalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes. J Clin Invest 96: 2304-2310, 1995.
21. Decker K: Biologically active products of stimulated liver macrophages (Kupffer cells). Eur J Biochem 192: 245-261, 1990.
22. Stachura J, Tarnawski A, Ivcy KJ, Mach T, Bogdal J, Szczudrawa J and Klimczyk B: Prostaglandin protection of carbon tetrachloride-induced liver cell necrosis in rats. Gastroenterology 81:211-217,1981.
23. Winwood PJ and Arthur MJP: Kupffer cells: their activation and role in animal models of liver injury and human liver disease. Semin Liver Dis 10:50-59, 1993.
24. Okamoto H, Shoin S, Koshimura S and Shimizu R: Studies on anticancer and streptolysin S-fouring abilities of hemolytic streptococci. Jpn J Microbiol 11: 323-326, 1967.